The test will be accessible via healthcare professional referrals in Western Australia and the Northern Territory.

Proteomics International Laboratories has launched its novel PromarkerD test for diabetic kidney disease in WA and the NT before expanding Australia-wide.

Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce the official laun ...

PORTLAND, IL, UNITED STATES, March 11, 2025 /EINPresswire / -- The proteomics market is witnessing significant growth propelled by advancements in technology, such as mass spectrometry and protein ...

Proteomics International Laboratories can roll out its novel diabetes-related blood test in the US, having received ...

The modern mass spectrometer is a rather complex instrument with many operational parameters; the data sets generated are similarly complex and often rather voluminous. Therefore, MIAPE-MS does ...

Proteomics International aptly has chosen World Kidney Day to launch its predictive test for diabetic kidney disease locally.

Enabling well-powered studies, absolute quantification, and unlimited content flexibility. GEN spoke with Milad Dagher, PhD, CEO and co-founder of Nomic, about how their nELISA platform is ...

The proteoCHIP LF 48 is a state-of-the-art label-free single-cell proteomics sample preparation solution. Designed for ...

Singular Genomics Systems (NASDAQ:OMIC – Get Free Report) will likely be issuing its quarterly earnings data after the market ...